The role of P-glycoprotein in intestinal tumorigenesis: Disruption of mdr1a suppresses polyp formation in ApcMin/+ mice

Carcinogenesis

Volumn 24, Issue 7, 2003, Pages 1219-1224

  Mochida, Yasushi ^a,b   Taguchi, Ken Ichi ^a   Taniguchi, Shuichi ^a   Tsuneyoshi, Masazumi ^a   Kuwano, Hiroyuki ^b   Tsuzuki, Teruhisa ^c   Kuwano, Michihiko ^a,d   Wada, Morimasa ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; GLYCOPROTEIN P; XENOBIOTIC AGENT;

ACTIVE TRANSPORT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL TYPE; CONTROLLED STUDY; DNA DAMAGE; GENE DISRUPTION; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE POLYP; INTESTINE TUMOR; LARGE INTESTINE; MOUSE; MOUSE STRAIN; NONHUMAN; ORGAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SMALL INTESTINE; TISSUE;

ANIMALS; APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BROMODEOXYURIDINE; CELL DIVISION; CELL MOVEMENT; DISEASE PROGRESSION; DNA DAMAGE; DRUG RESISTANCE, MULTIPLE; ENTEROCYTES; FEMALE; GENES, APC; IMMUNOENZYME TECHNIQUES; INTESTINAL POLYPS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; P-GLYCOPROTEINS;

EID: 0041668155     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg073     Document Type: Article

References (21)

1. Leslie,E.M., Deeley,R.G. and Cole,S.P. (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology, 167, 3-23.
2. Kuwano,M., Toh,S., Uchiumi,T., Takano,H., Kohno,K. and Wada,M. (1999) Multidrug resistance-associated protein subfamily transporters and drug resistance. Anticancer Drug Des., 14, 123-131.
3. Dietrich,C.G., de Waart,D.R., Ottenhoff,R., Schoots,I.G. and Elferink,R.P. (2001) Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. Mol. Pharmacol., 59, 974-980.
4. Hsing,S., Gatmaitan,Z. and Arias,I.M. (1992) The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology, 102, 879-885.
5. Johnstone,R.W., Ruefli,A.A. and Smyth,M.J. (2000) Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem. Sci., 25, 1-6.
6. Kohno,K., Sato,S., Takano,H., Matsuo,K. and Kuwano,M. (1989) The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Commun., 165, 1415-1421.
7. Weinstein,R.S., Jakate,S.M., Dominguez,J.M. et al. (1991) Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res., 51, 2720-2726.
8. Buschman,E., Lepage,P. and Gros,P. (1994) P-glycoprotein homologues. Cancer Treat. Res., 73, 17-39.
9. Schinkel,A.H., Smit,J.J., van Tellingen,O. et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491-502.
10. Moser,A.R., Pitot,H.C. and Dove,W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
11. Jen,J., Powell,S.M., Papadopoulos,N., Smith,K.J., Hamilton,S.R., Vogelstein,B. and Kinzler,K.W. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54, 5523-5526.
12. Johnson,D.R., Finch,R.A., Lin,Z.P., Zeiss,C.J. and Sartorelli,A.C. (2001) The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice. Cancer Res., 61, 1469-1476.
13. Dietrich,W.F., Lander,E.S., Smith,J.S., Moser,A.R., Gould,K.A., Luongo,C., Borenstein,N. and Dove,W. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75, 631-639.
14. Gustafson,D.L. and Long,M.E. (2001) Alterations in P-glycoprotein expression in mouse tissues by doxorubicin: implications for pharmacokinetics in multiple dosing regimens. Chem. Biol. Interact., 138, 43-57.
15. Hall,P.A., Coates,P.J., Ansari,B. and Hopwood,D. (1994) Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J. Cell. Sci., 107, 3569-3577.
16. Johnson,I.T. (2002) Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food Chem. Toxicol., 40, 1171-1178.
17. Andreassen,A., Vikse,R., Steffensen,I.L., Paulsen,J.E. and Alexander,J. (2001) Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele. Mutagenesis, 16, 309-315.
18. Luongo,C., Moser,A.R., Gledhill,S. and Dove,W.F. (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res., 54, 5947-5952.
19. Shih,I.M., Wang,T.L., Traverso,G., Romans,K., Hamilton,S.R., Ben-Sasson,S., Kinzler,K.W. and Vogelstein,B. (2001) Top-down morphogenesis of colorectal tumors. Proc. Natl Acad. Sci. USA, 98, 2640-2645.
20. Yamada,T., Mori,Y., Hayashi,R., Takada,M., Ino,Y., Naishiro,Y., Kondo,T. and Hirohashi,S. (2003) Suppression of intestinal polyposis in Mdr1-deficient Apc(Min/+) Mice. Cancer Res., 63, 895-901.
21. Hoffmeyer,S., Burk,O., von Richter,O., Arnold,H.P., Brockmoller,J., Johne,A., Cascorbi,I., Gerloff,T., Roots,I., Eichelbaum,M. and Brinkmann,U. (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA, 97, 3473-3478.